On the Problem of Differential Diagnosis of Inflammatory and Functional Bowel Diseases
Journal Title: Гастроентерологія - Year 2013, Vol 2, Issue 48
Abstract
The paper describes the problems of differential diagnosis of inflammatory (ulcerative colitis, Crohn’s disease) and functional (irritable bowel syndrome) disease of the intestine. The necessity of such differential diagnosis in certain categories of patients was noted. The possibilities of instrumental and laboratory methods of study are shown. Particular attention is paid to the definition of fecal tests — calprotectin and lactoferrin. An analysis of the studies of their information content has been carried out.
Authors and Affiliations
I. Ya. Budzak
Clinical and Pathogenetic Features of Nonalcoholic Fatty Liver Disease in Patients with Bronchial Asthma and Obesity
Due to comorbidity of bronchial asthma (BA) and obesity, there occurs the formation of nonalcoholic fatty liver disease (NAFLD), in which changes of pathogenic links of the disease are observed. Objective of the study: t...
Psychological Dysadaptation in Patients with Gastroesophageal Reflux Disease: Review and Own Researches
The article presents up-to-date data concerning psychosomatic problem in medicine, in particular world experience of studying disorders of psychological of adaptation in patients with gastroesophageal reflux disease (GER...
Retrospective Analysis of the Effectiveness of Treating Patients with Duodenal Peptic Ulcer
The article presents a retrospective analysis of the effectiveness of treating patients with duodenal peptic ulcer (DPU) during 10 years, after the implementation of Maastricht consensus statements in clinical practice....
Clinical and Pathogenetic Aspects of Chronic Pancreatitis of Biliary Genesis and Obesity
The article presents an analysis of the literature data on the connection of chronic pancreatitis of biliary genesis and obesity. The obesity is associated with hormonal disorders with excessive production of hormones wi...
Efficiency of Combined Hepatoprotector Forceliv in the Treatment of Chronic Diffuse Liver Disease
The article presents the results of a study of serum alanine aminotransferase levels in patients with chronic diffuse liver diseases on the background of combined hepatoprotector Forceliv application. According to the fi...